Trial · NCT01646255
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Absolute Change in Absolute Time Spent 'Off' From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Placebo Treated Subjects) | -1.13 | Standard Deviation 3.20 | hours | |
| Absolute Change in Absolute Time Spent 'Off' From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Rotigotine Treated Subjects) | -2.36 | Standard Deviation 2.83 | hours | |
| Percentage of Responders From Baseline to the End of the Doubleblind Maintenance Period | Full Analysis Set (Placebo Treated Subjects) | 36.9 | percentage of participants | ||
| Percentage of Responders From Baseline to the End of the Doubleblind Maintenance Period | Full Analysis Set (Rotigotine Treated Subjects) | 48.8 | percentage of participants | ||
| Percent Change in Absolute Time Spent Off From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Placebo Treated Subjects) | -15.0 | Standard Deviation 56.56 | percent change | |
| Percent Change in Absolute Time Spent Off From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Rotigotine Treated Subjects) | -36.03 | Standard Deviation 43.03 | percent change | |
| Percent Change in Relative Time Spent Off From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Placebo Treated Subjects) | -14.86 | Standard Deviation 53.26 | percent change | |
| Percent Change in Relative Time Spent Off From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Rotigotine Treated Subjects) | -34.97 | Standard Deviation 43.87 | percent change | |
| Change in Absolute Time Spent on From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Placebo Treated Subjects) | 0.94 | Standard Deviation 3.08 | hours | |
| Change in Absolute Time Spent on From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Rotigotine Treated Subjects) | 2.05 | Standard Deviation 2.98 | hours | |
| Change in Relative Time Spent on From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Placebo Treated Subjects) | 6.78 | Standard Deviation 19.61 | hours | |
| Change in Relative Time Spent on From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Rotigotine Treated Subjects) | 14.49 | Standard Deviation 18.70 | hours | |
| Percent Change in Absolute Time Spent on From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Placebo Treated Subjects) | 13.53 | Standard Deviation 42.74 | percent change | |
| Percent Change in Absolute Time Spent on From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Rotigotine Treated Subjects) | 368.55 | Standard Deviation 4446.55 | percent change | |
| Percent Change in Relative Time Spent on From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Placebo Treated Subjects) | 14.99 | Standard Deviation 42.60 | percent change | |
| Percent Change in Relative Time Spent on From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Rotigotine Treated Subjects) | 616.80 | Standard Deviation 7667.58 | percent change | |
| Change in the Number of Off Periods From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Placebo Treated Subjects) | -0.61 | Standard Deviation 1.59 | Number of 'off' Periods | |
| Change in the Number of Off Periods From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Rotigotine Treated Subjects) | -0.89 | Standard Deviation 1.32 | Number of 'off' Periods | |
| Change in Status of the Subject (on) After Wake-up With Troublesome Dyskinesia From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Placebo Treated Subjects) | 2.42 | Standard Deviation 21.70 | percentage of days | |
| Change in Status of the Subject (on) After Wake-up With Troublesome Dyskinesia From Baseline to the End of Double-blind Maintenance Period | Full Analysis Set (Rotigotine Treated Subjects) | 1.24 | Standard Deviation 16.90 | percentage of days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01646255/results